MAPT and Cognitive impairment: In conclusion, our results indicate that Alzheimer’s disease brain homogenate inoculation induces an encephalopathy characterized by neuronal loss, progressive atrophy, neuronal activity alterations and cognitive impairments as well as sparse β-amyloid and tau depositions.